{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:49:13Z","timestamp":1776422953947,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.neuropharm.2016.01.005","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T08:30:53Z","timestamp":1452069053000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine"],"prefix":"10.1016","volume":"109","author":[{"given":"Diane I.","family":"Bitzinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"T\u00fcmmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Bundscherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Hopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Trabold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard M.","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"York A.","family":"Zausig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2016.01.005_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003088-198611030-00005","article-title":"Clinical pharmacokinetics of cholinesterase inhibitors","volume":"11","author":"Aquilonius","year":"1986","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.01.005_bib2","first-page":"369","article-title":"Effects of carbon dioxide-induced anesthesia on cholinergic parameters in rat brain","volume":"44","author":"Berger-Sweeney","year":"1994","journal-title":"Lab. Anim. Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.01.005_bib3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.imbio.2013.01.003","article-title":"Modulation of immune functions in polymorphonuclear neutrophils induced by physostigmine, but not neostigmine, independent of cholinergic neurons","volume":"218","author":"Bitzinger","year":"2013","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.neuropharm.2016.01.005_bib4","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0006-2952(02)01029-8","article-title":"DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase","volume":"63","author":"Boeck","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2016.01.005_bib5","first-page":"RA214","article-title":"Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation","volume":"13","author":"Das","year":"2007","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.01.005_bib6","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/cc13711","article-title":"Serum butyrylcholinesterase predicts survival following extracorporeal membrane oxygenation after cardiovascular surgery","volume":"18","author":"Distelmaier","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2016.01.005_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.01.005_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1345\/aph.1Q515","article-title":"Intravenous neostigmine for postoperative acute colonic pseudo-obstruction","volume":"46","author":"Elsner","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.01.005_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/bja\/73.2.241","article-title":"Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium","volume":"73","author":"Fleming","year":"1994","journal-title":"Br. J. Anaesth."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.01.005_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1399-6576.1989.tb02991.x","article-title":"Reversal of postoperative somnolence using a two-rate infusion of physostigmine","volume":"33","author":"Hartvig","year":"1989","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neuropharm.2016.01.005_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2011.03.004","article-title":"In\u00a0vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acethylcholinesterase from different species","volume":"1","author":"Herkert","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.01.005_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.CCM.0B013E31816208B3","article-title":"Pharmacologic cholinesterase inhibition improves survival in experimental sepsis","volume":"36","author":"Hofer","year":"2008","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.01.005_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0003-2697(75)90423-6","article-title":"A\u00a0rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations","volume":"64","author":"Johnson","year":"1975","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.01.005_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neuropharm.2007.04.002","article-title":"Targeting the cholinergic system as a therapeutic strategy for the treatment of pain","volume":"53","author":"Jones","year":"2007","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2016.01.005_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/109158180302200604","article-title":"In\u00a0vitro inhibition of blood cholinesterase activities from horse, cow, and rat by tetrachlorvinphos","volume":"22","author":"Karanth","year":"2003","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.01.005_bib16","first-page":"13","article-title":"Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease","volume":"28","author":"Lanct\u00f4t","year":"2003","journal-title":"J.\u00a0Psychiatry Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.01.005_bib17","first-page":"528","article-title":"Postoperative routine use of physostigmine on vigilance, cardiovascular parameters and need of analgesics","volume":"38","author":"Latasch","year":"2003","journal-title":"Anasthesiol. Intensivmed. Notfallmed. Schmerzther."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.01.005_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1471-4159.2000.751320.x","article-title":"Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse","volume":"75","author":"Li","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.01.005_bib19","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jssc.200800701","article-title":"Screening of acethylcholinesterase inhibitors by CE after enzymatic reaction at capillary inlet","volume":"32","author":"Mart\u00edn-Biosca","year":"2009","journal-title":"J.\u00a0Sep. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.01.005_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-065X.2012.01138.x","article-title":"Rethinking inflammation: neural circuits in the regulation of immunity","volume":"248","author":"Olofsson","year":"2012","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.01.005_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/tpj.2010.61","article-title":"Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease","volume":"11","author":"Patterson","year":"2011","journal-title":"Pharmacogenomics J."},{"issue":"12","key":"10.1016\/j.neuropharm.2016.01.005_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex \u2013 linking immunity and metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2016.01.005_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000346723","article-title":"Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain","volume":"35","author":"Sifringer","year":"2013","journal-title":"Dev. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.01.005_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0090-9556(25)06796-0","article-title":"Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration","volume":"15","author":"Somani","year":"1987","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.01.005_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00204-012-0987-z","article-title":"A\u00a0physiologically based pharmakokinetic model for the oxime TMB-4: stimulation of rodent and human data","volume":"87","author":"Sterner","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.01.005_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/rvsc.2001.0465","article-title":"Determination of whole blood cholinesterase in different animal species using specific substrates","volume":"70","author":"Tecles","year":"2001","journal-title":"Res. Vet. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.01.005_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14017430601085948","article-title":"Functional and phenotypic changes in polymorphonuclear neutrophils induced by catecholamines","volume":"41","author":"Trabold","year":"2007","journal-title":"Scand. Cardiovasc. J."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.01.005_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/bja\/aep372","article-title":"Interaction of physostigmine and alfentanil in a human pain model","volume":"104","author":"Wehrfritz","year":"2010","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.01.005_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4097\/kjae.2013.65.6.501","article-title":"Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients","volume":"65","author":"Woo","year":"2013","journal-title":"Korean J. Anesthesiol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2016.01.005_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2010.10.009","article-title":"Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and guinea pig acetylcholinesterase","volume":"200","author":"Worek","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2016.01.005_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chroma.2007.02.024","article-title":"Characterization of procaine metabolism as probe for the butyrylcholinesterase enzyme investigation by simultaneous determination of procaine and its metabolite using capillary electrophoresis with electrochemiluminescence detection","volume":"1154","author":"Yuan","year":"2007","journal-title":"J.\u00a0Chromatogr. A"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.01.005_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000204276","article-title":"Investigation on the acetylcholinesterase activity of erythrocytes, platelets and plasma in different animal species","volume":"9","author":"Zajicek","year":"1953","journal-title":"Acta Haematol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T01:59:15Z","timestamp":1748743155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816300053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":32,"alternative-id":["S0028390816300053"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}